BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18988226)

  • 1. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis of epidemiological studies.
    Suzuki R; Orsini N; Mignone L; Saji S; Wolk A
    Int J Cancer; 2008 Apr; 122(8):1832-41. PubMed ID: 18067133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
    Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
    Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A
    Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol consumption and breast cancer oestrogen and progesterone receptor status.
    Enger SM; Ross RK; Paganini-Hill A; Longnecker MP; Bernstein L
    Br J Cancer; 1999 Mar; 79(7-8):1308-14. PubMed ID: 10098777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
    Niraula S; Ocana A; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women.
    Rosner B; Eliassen AH; Toriola AT; Hankinson SE; Willett WC; Natarajan L; Colditz GA
    Breast Cancer Res Treat; 2015 Apr; 150(3):643-53. PubMed ID: 25796612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.